Literature DB >> 2851606

Antibodies to human cytomegalovirus structural polypeptides during primary infection.

M P Landini1, E Rossier, H Schmitz.   

Abstract

This study aimed at broadening the understanding of the immunogenic potential of cytomegalovirus (CMV) structural polypeptides during natural infection and to ascertain their possible use in serological diagnosis. Immunoblotting was used to analyse the appearance and development of serum IgG and IgM against human CMV structural polypeptides in sequential sera from renal transplant recipients during the first 1-3 months of primary CMV infection. The results showed that the first IgG to appear is specific for a polypeptide of 66 kDa and these antibodies appear either alone or together with others against another polypeptide of 82 kDa. IgG to the 150 kDa protein appears at least one week later. The first IgM to appear reacts preferentially with a 38 and 66 kDa polypeptide. The early detection of antibody against the major viral antigenic proteins in the diagnosis of CMV primary infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851606     DOI: 10.1016/0166-0934(88)90113-9

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  20 in total

1.  Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients.

Authors:  H Miller; B McCulloch; M P Landini; E Rossier
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays.

Authors:  T Lazzarotto; S Brojanac; G T Maine; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay.

Authors:  T Lazzarotto; G T Maine; P Del Monte; H Frush; K Shi; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

5.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.

Authors:  V A Sundqvist; W Xu; B Wahren
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  Human cytomegalovirus (HCMV)-specific immunoglobulin E as a serologic marker for HCMV infection in immunocompromised patients.

Authors:  B Weber; W Braun; B Tyralla; A Hamann; H W Doerr
Journal:  Clin Investig       Date:  1992-06

8.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Humoral immune response to human cytomegalovirus DNA polymerase.

Authors:  M P Landini; T Lazzarotto; P F Ertl
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

Review 10.  Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.

Authors:  B Weber; W Braun; J Cinatl; H W Doerr
Journal:  Clin Investig       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.